LLY CEO: Aim to resume growth and expand margins

7:18 AM ET Thu, 22 Oct 2015

John Lechleiter, Eli Lilly chairman & CEO, discusses the impact of the strong dollar on revenues as the company posts mixed quarterly results which beat on earnings. Also Lechleiter provides an outlook on several drugs, including data on clinical trials for its diabetes drug.